2.Advances in research and development of universal influenza vaccines.
Li-Xia ZHANG ; Jian-Fang ZHOU ; Yue-Long SHU ; Bao-Shou YANG ; Zhao-Qing HE
Chinese Journal of Virology 2014;30(1):73-78
Vaccination is the primary strategy for the prevention and control of pandemic influenza. Because influenza virus is highly variable across strains, universal influenza vaccines need to be developed to address this problem. This review describes the research progress in conserved epitopes of influenza virus, the advances in the research and development of universal influenza vaccines based on the relatively conserved sequences of NP, M2e, HA2, and headless HA, the mechanisms of cross-protection, and the methods to improve cross-protection.
Animals
;
Cross Reactions
;
Humans
;
Orthomyxoviridae
;
immunology
;
Species Specificity
;
Viral Proteins
;
immunology
;
Viral Vaccines
;
genetics
;
immunology
3.HIV/AIDS vaccine development: are we walking out from the dark?
Yan-Min WAN ; You-Chun WANG ; Jian-Qing XU
Chinese Medical Journal 2010;123(23):3489-3494
4.Antigenic relationship between mugwort and ragweed pollens by crossed immunoelectrophoresis.
Hae Sim PARK ; Mi Jung KIM ; Hee Bom MOON
Journal of Korean Medical Science 1994;9(3):213-217
Mugwort and ragweed pollens have been considered as important respiratory allergens in Korea. These two pollens are abundant in the air of Seoul from August through October. Many ragweed-sensitive patients have shown concurrent sensitivities to mugwort pollen. However the antigenic relationship between these two pollens has not been clarified. To observe the cross-reactivity between them, we developed polyclonal anti-mugwort and anti-ragweed antibodies by immunization on New Zealand white rabbits, and performed crossed immunoelectrophoresis(CIE) with two pollen extracts. Five precipitation lines were formed by mugwort and anti-mugwort antibody. One precipitation line was formed by ragweed and anti-ragweed antibody. There was no reaction from mugwort and anti-ragweed antibody, and from ragweed and anti-mugwort antibody. These results indicate that there is no cross-antigenicity between mugwort and ragweed pollens.
Animal
;
Antibodies/immunology
;
Cross Reactions
;
Immunoelectrophoresis, Two-Dimensional
;
Pollen/*immunology
;
Rabbits
5.Occupational Asthma Caused by Inhalable Royal Jelly and Its Cross-reactivity with Honeybee Venom.
Chinese Medical Journal 2016;129(23):2888-2889
Adult
;
Allergens
;
immunology
;
Animals
;
Asthma, Occupational
;
diagnosis
;
etiology
;
Bee Venoms
;
immunology
;
Bees
;
immunology
;
Cross Reactions
;
Fatty Acids
;
immunology
;
Female
;
Humans
6.Chinese Bellflower Root Anaphylaxis: IgE-Binding Components and Cross-Reactivity With Mugwort and Birch.
Sae Hoon KIM ; Sang Min LEE ; Heung Woo PARK ; Sang Heon CHO ; Kyung Up MIN ; You Young KIM ; Yoon Seok CHANG
The Korean Journal of Internal Medicine 2009;24(3):279-282
A 56-year-old man who had suffered from seasonal rhinitis in spring and autumn experienced recurrent generalized urticaria and an oral burning sensation after eating several cooked herbs for 3 months. A skin-prick test showed positive responses to various pollens, celery, Chinese bellflower, and arrowroot. The Chinese bellflower-specific IgE ELISA OD value was 1.547. Oral challenge with unprocessed raw Chinese bellflower root provoked oral burning sensation, eyelid swelling, generalized urticaria, and hypotension. In an ELISA inhibition test, IgE binding to Chinese bellflower was significantly inhibited by Chinese bellflower, mugwort, and birch pollen extract. SDS-PAGE and immunoblot assay revealed nine IgE-binding components, and common protein bands were detected in the range of 40~55 kDa (Chinese bellflower-mugwort-birch) and 14 kDa (Chinese bellflower-birch). Chinese bellflower root can cause anaphylaxis and may have cross-reactivity with mugwort and birch.
Anaphylaxis/*etiology
;
Artemisia/*immunology
;
Betula/*immunology
;
Cross Reactions
;
Humans
;
Immunoglobulin E/*immunology
;
Male
;
Middle Aged
;
Platycodon/*immunology
7.Selection of donor in mismatched hematopoietic stem cell transplantation by CREG, residue match and HLA three-dimensional structure.
Hong-Xing HAN ; Fan-Hua KONG ; Yong-Zhi XI ; Yu-Ying SUN ; Li JIN ; Nan LIU ; Si-Qi GUO
Journal of Experimental Hematology 2002;10(6):553-556
After search at hematopoietic stem cell banks for transplant donors, there may be several donors matched with given standards. To determine the most appropriate donor for a specific patient, the potential donors were analyzed and compared by three methods. The first is cross-reactive group (CREG) antigens, which defined as the public antigens that shared specific serological reaction patterns. The second is residue match theory, which concerned the three residues oriented upward toward the T-cell receptor. The third is comparing HLA three-dimensional structure models. The results of the three methods were not completely accorded in our case. However, some less matched donors could be excluded from the candidates and the range of selection was further reduced. It is concluded that combined application of three methods would contribute in selecting donor for hematopoietic stem cell transplantation in clinics.
Cross Reactions
;
HLA Antigens
;
immunology
;
Hematopoietic Stem Cell Transplantation
;
Histocompatibility Testing
;
Humans
;
Tissue Donors
8.Preparation of rabbit monoclonal antibody against cGMP and development of competitive ELISA for cGMP.
Xing-mei TAN ; Hai-feng HU ; Shu-qing CHEN
Journal of Zhejiang University. Medical sciences 2015;44(4):423-428
OBJECTIVETo prepare rabbit monoclonal antibody (RabMab) against guanosine 3', 5'-cyclic monophosphate (cGMP) and to develop a competitive ELISA for the detection of cGMP.
METHODSNew Zealand white rabbits were immunized with synthesized cGMP-keyhole limpet hemoeyanin (cGMP-KLH) to prepared a RabMAb with monoclonal antibody technique of Epitomics. A competitive ELISA kit was produced with cGMP RabMAb. The specificity, the precision and the recoveries of the method were determined.
RESULTSThe RabMAb with high sensitivity towards cGMP were prepared with an antibody timer of 3.1 ng/mL and 50% inhibitive concentration (IC50) of 12.57 ng/mL. The cGMP RabMAb had 33% cross-reactivity to inosine 3', 5'-cyclic monophosphate (cIMP) and little or no cross-reactivity to other compounds. A competitive ELISA was developed for detection of cGMP. The range of detection was 0~120 ng/mL with a minimal limit of 1.95 ng/mL. The recovery of assay was 89%~103%. The inter-assay and intra-assay coefficient variations were below 11.68% and 13.85%, respectively.
CONCLUSIONThe RabMab against cGMP with high affinity and high specificity has been generated successfully, and a competitive ELISA for detection of cGMP has been developed with the prepared cGMP RabMAb.
Animals ; Antibodies, Monoclonal ; biosynthesis ; Antibody Specificity ; Cross Reactions ; Cyclic GMP ; immunology ; Enzyme-Linked Immunosorbent Assay ; Rabbits
9.Cross-reactivity between sera from dogs experimentally infected with Dirofilaria immitis and crude extract of Toxocara canis.
Kun Ho SONG ; Mineo HAYASAKI ; Kyu Woan CHO ; Sang Eun LEE ; Duck Hwan KIM
The Korean Journal of Parasitology 2002;40(4):195-198
This study was performed to investigate whethere there is cross-reactivity between Dirofilaria immitis and three intestinal nematodes of dogs. In ELISA, D. immitis-infected dog sera obtained at the 4th molting stage (9-11 weeks) and microfilaremic stage (25-30 weeks) were shown to be highly reactive with crude extract of T. canis. In immunoblotting, some antigenic fractions, 44, 57, 88, 100 kDa of crude extract of T. canis, were found to be positive reaction with sera of dogs infected with D. immitis. However, little or no cross-reaction were observed between sera of D. immitis-infected dogs and crude extract antigen of T. vulpis or A. caninum. These result suggest that there are partial cross reaction between sera of D. immitis-infected dogs and the antigen of T. canis.
Animals
;
Antibodies, Helminth/*immunology
;
Antigens, Helminth/*immunology
;
Cross Reactions
;
Dirofilaria immitis/*immunology
;
Dirofilariasis/*immunology
;
Dogs
;
Enzyme-Linked Immunosorbent Assay
;
Immunoblotting
;
Toxocara canis/*immunology
10.Study on serological cross-reactivity of six pathogenic phleboviruses.
Wei WU ; Shuo ZHANG ; Quan-Fu ZHANG ; Chuan LI ; Mi-Fang LIANG ; De-Xin LI
Chinese Journal of Virology 2014;30(4):387-390
This article aimed to study the antigenicity of nucleocapsid proteins (NPs) in six pathogenic phleboviruses and to provide theoretical evidence for the development of serological diagnostic reagents. NPs of six pathogenic phleboviruses were expressed and purified using a prokaryotic expression system and rabbits were immunized with individual recombinant NPs. Cross-reactions among NPs and rabbit sera were determined by both indirect ELISA and Western blotting analyses, and the sera titer was determined by indirect ELISA. Furthermore, sera from SFTS patients were also detected by each recombinant NP as a coating antigen using indirect ELISA. The cross-reactions and the sera titer were subsequently determined. Both the concentration and purity of recombinant NPs of six pathogenic phleboviruses met the standards for immunization and detection. The results of indirect ELISA and Western blotting showed that each anti-phlebovirus NP rabbit immune serum had potential serological cross-reactivity with the other five virus NP antigens. Furthermore, the sera from SFTS patients also had cross-reactivity with the other five NP antigens to a certain extent. Our preliminary study evaluated the antigenicity and immune reactivity of six pathogenic phleboviruses NPs and laid the foundation for the development of diagnostic reagents.
Animals
;
Antibodies, Viral
;
immunology
;
Antigens, Viral
;
genetics
;
immunology
;
Cross Reactions
;
Humans
;
Nucleocapsid Proteins
;
genetics
;
immunology
;
Phlebotomus Fever
;
diagnosis
;
immunology
;
virology
;
Phlebovirus
;
classification
;
genetics
;
immunology
;
isolation & purification
;
Rabbits